|
|
|
(State or other jurisdiction of
incorporation) |
(Commission File Number)
|
(IRS Employer
Identification Number) |
|
(Address of principal executive offices)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Exhibit No.
|
Description
|
|
99.1
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
Vistagen Therapeutics, Inc.
|
||
Date: January 8, 2024
|
By:
|
/s/ Shawn K. Singh
|
Shawn K. Singh
Chief Executive Officer
|
Exhibit 99.1
<7.#2XO.UH,?FL9#K&V;O\$_^=9^FK2T5JU?2#F1SX'P35UL
MC69\EJLQ.CAKO3R2-7AH>X:[?5%;K&MJ]C'>GCV^HSU/5^U>A55ZE"D,/I9#
MXO(+=WI[2UQ>(K]-[MP8QGY_ZI_/L^AZMGIH7YH(\FIB85N0_;2-SAJ 5ICI
M_5ZG#U[/19P+'OAO]F$J<3IHL!9DO:W '!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP
M0V5H:4AZ D!\@'Z @,"# (4 AT")@(O
M C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+! LL"U0+@ NL"]0, PL#
M%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#QP/3 ^ #[ /Y! 8$$P0@
M!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P!/X%#044%]@8&!A8&)P8W!D@&609J!GL&C :=!J\&P ;1
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M&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@;""8(,0@\"$<(4@A=2&A
M( &YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]
M07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82 A..%1X6K
MA@Z& U%KME,C '8M\1D
M/-C9\RZW+J=_IJV(25XZM?1']TI KR)'AVRSPHJ6A=.>!?5RF[@="1\"K-.3?72^ACW"JTR]
MDG:=-OT?H_15[[!T61MS3(VZ.<(=N
&UP34TZ26YS=&%N
M8V5)1#TB>&UP+FEI9#HX,C!B,#(P8RUD-6%A+3DY-&,M.&-B-BTR,S)A,6)F
M83DS-V0B('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#TB03
U3>3/RQ-K6+0;9YB:/7
1-/EF3#/&8J3B9<,H>J/) CS;K44BV
M>HV+P[$_O#;R6VF@&PB-/A:E.AZ^&79(FJ#3@R"]PS>[\W0WZB!@(9(1QXMLH
M'8US%C@ -]7+GJK%=& WGUBXJ^FWL%O()*RNQ*H03W(VWS,A';=PLA)-AB=O
MIUWJFJ26S7*I&6/UN2)JA5%:L/&I&V7'T!QXCBENCY[6T\M-/=6I6^C<<9'V
MY^'*GTY$$RW3*,<9M*K1_KTLLZW1CAH R 4+D'N?#+)S67ES0M#C,%E$G-:^N[
N;+%DB1NZO-CD"\UUV[EMC';JQ^#CRW(HWR.9V+'Q"W6YID
R@B(-O. 2M'2E1]&3))8
M.5G=L4KN%/J1YRJ>(V%>_:N2B*Y((2VQT2UNHA-=Q<[QJ@RO0@J/V?D<)D4>
M&"\X\U>3-!:ZDNM'DN] U-FY7I@9GM9O 21DT'S&9F#.:WW<'/IA=AB=EY(C
MU>X@L[S7Y)KBU/KDV[!$(Z\#3>GMETLVVT:<>. 2/#Q60SVXL4BET[3M/@3T
MHD^T "21]H[>)S%$S+